username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
Biotech China to Showcase Industrial Parks

Clicks:454 Date:04/09/14

Biotech China, the first major Chinese biotech exhibition and conference, will hold the 2014 Biotech China on 14-16th May, 2014 in Nanjing, China. For the first time open the door to the world, Biotech China puts its main focus on the display of latest technologies and products in the bio pharmaceutical field and coupled with a variety of business oriented fringe programs.

Featured with extensive capital invest, high risk, and long R&D circle, among others, developing bio pharmaceutical industry requires high-tech scientific infrastructure and sustainable human resource for R&D.

Built in economically developed areas and close to talents pools, Industrial parks are playing an essential and indispensable role as the carrier/incubator for start-ups and SMEs in the development of the new emerging bio pharmaceutical industry in China.

Biotech China will be an excellent opportunity to meet the key players in the Chinese and international bio industrial parks and incubator scenes. Bio Alps from Switzerland and clusters from other countries will also be present and participate in the first China Summit Forum on Bio-Medicine Industrial Park Development on the second day of the exhibition (May 15).

The participating industrial parks include Nanjing Zhongshan Life Science Park, Nanjing Biotech and Pharmaceutical Valley, Jiangsu Life Science & Technology Innovation Park, Wuhan National Bio Industry Base (BioLake), Shandong International Biotechnology Park, Beijing Yizhuang Biomedical Park, Chengdu Hi-Tech Industrial Development Zone, as well as Bio Alps.

Over 70 dedicated medical life sciences companies and institutions are located in The Nanjing Zhongshan Life Science Park including: Nanjing Jinling Automatic Controlling Temperature Bed CO., LTD., Nanjing Shenzhou Seed Co., Ltd., Nanjing Qinshantang Biotechnology Co., Ltd., Nanjing Cheery Biotech Co., Ltd., Nanjing Yujie Cleaner Co., Ltd., Vazyme Biotech (Nanjing) Co., Ltd., Nanjing Kingman Froeasy Science and Technology Development Co., Ltd., Nanjing F-zone Biotech Co., Ltd., Feng He Biotech Co., Ltd., Nanjing Honglibao Biotech Co., Ltd., Nanjing Dingshikang Pharmaceutical Co., Ltd, Nanjing Weikexin Biotech Co., Ltd., Nanjing Kemaike Pharmaceutical Co., Ltd., Nanjing Jinling Automatic Controlling Temperature Bed CO., LTD., Nanjing Shenzhou Seed Co., Ltd., Nanjing Qinshantang Biotechnology Co., Ltd., Nanjing Cheery Biotech Co., Ltd., Nanjing Yujie Cleaner Co., Ltd., Vazyme Biotech (Nanjing) Co., Ltd., Nanjing Kingman Froeasy Science and Technology Development Co., Ltd., Nanjing F-zone Biotech Co., Ltd., Feng He Biotech Co., Ltd., Nanjing Honglibao Biotech Co., Ltd., Nanjing Dingshikang Pharmaceutical Co., Ltd, Nanjing Weikexin Biotech Co., Ltd., and Nanjing Kemaike Pharmaceutical Co., Ltd.

To Meet Nanjing Zhongshan Life Science Park at L17 in Hall A.

Bio Alps
Taking advantage of the new FTA between Switzerland and China, Bio Alps, the life science cluster of Western Switzerland, will lead a delegation of 8 Swiss companies to 2014 Biotech China. Bio Alps promotes synergies between academia, entrepreneurs, investors, authorities and new businesses to translate ideas into new products and bring new technologies to market. Member companies include: Ecole Polytechnique Fédérale de Lausanne (EPFL), Swiss Institute of BioInformatics (SIB), Swiss Centre for Electronics and Microtechnology (CSEM), Lausanne University Hospital (CHUV), University Hospitals of Geneva (HUG), University of Lausanne (UNIL), University of Geneva (UNIGE), University of Neuchâtel (UNINE), University of Fribourg (UNIFR), University of Applied Sciences of Western Switzerland of Valais (HES-SO), University of Engineering and Management of Vaud (HEIG-VD), and Haute école du paysage, d’ingénierie et d’architecture de Genève (HEPIA).

To contact Bio Alps, please visit the booth F17 in Hall A.

About CRO
US Gene Synthesis Heads CROs at Biotech China

GenScript, the largest gene synthesis provider in the U.S., and a leading biology CRO in the world, has recently confirmed its participation at 2014 Biotech China.

GenScript is a leading biology CRO focusing exclusively on early drug discovery and development services. Built on an assembly-line mode, one-stop solution, continuous improvement, and stringent IP protection, GenScript provides a comprehensive portfolio of services that include Bio-Reagent, Bio-Assay, Lead Optimization, and Antibody Drug Development which can be effectively integrated into a value chain and operations. The company develops pre-clinical drug candidates time-efficiently and cost-effectively.

For more CRO companies at Biotech China, please stay tuned at www.biotechchina-nj.com/en.

Contacts
Biotech China
Mr. Yunpeng Gong, +86-25--83518305
gongyp@biotechchina-nj.com
Fax: +86-25-83518322-818
Http://www.biotechchina-nj.com

More about Biotech China:
-Biotech China 2014 - The All China Biotech Conference & Exhibition
-Biotech China Show Preview

Related News>> more
advertisement

Copyright(C) 2006-2014 bio-equip    E-mail:web@bio-equip.cn   沪ICP备06040519号